quinazolines has been researched along with buquineran in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jackson, G; Jackson, PG; Jewitt, DE; Kitson, D | 1 |
| Dollery, CT; Follath, F; Kersting, F; Lewis, GR; Walden, RJ; Woolhouse, NM | 1 |
| Houslay, MD; Price, B; Pyne, NJ | 1 |
| Hecker, E; Pecar, S; Schara, M; Schmidt, R; Sorg, B | 1 |
| Muir, JG; Murray, AW | 1 |
| Carlier, J; D'Orio, V; el Allaf, D | 1 |
| Goyal, RK; Patel, VG | 1 |
| Been, M; Hillis, WS | 1 |
| Adams, P; Bruder, G; Buckner, R; Carmody, TJ; Cooper, C; Fava, M; Grannemann, BD; Kraemer, HC; Kurian, BT; McGrath, PJ; McInnis, M; Morris, DW; Ogden, RT; Oquendo, MA; Parsey, RV; Petkova, E; Phillips, ML; Pizzagalli, D; Toups, M; Trivedi, MH; Weissman, MM; Weyandt, S | 1 |
| Faro Viana, P; Gama Marques, J; Peralta, AR | 1 |
2 review(s) available for quinazolines and buquineran
| Article | Year |
|---|---|
The new inotropic phosphodiesterase inhibitors.
Topics: Aminopyridines; Amrinone; Calcium; Carbamates; Cardiotonic Agents; Cardiovascular Agents; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridones; Quinazolines; Stimulation, Chemical; Time Factors; Xanthines | 1984 |
Phosphodiesterase inhibitors: haemodynamic effects related to the treatment of cardiac failure.
Topics: Aminophylline; Animals; Carbamates; Heart Failure; Heart Rate; Hemodynamics; Humans; Myocardial Contraction; Phosphodiesterase Inhibitors; Quinazolines; Stimulation, Chemical | 1982 |
1 trial(s) available for quinazolines and buquineran
| Article | Year |
|---|---|
Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design.
Topics: Adult; Antidepressive Agents; Biomarkers; Brain; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Humans; Magnetic Resonance Imaging; Male; Patient Selection; Precision Medicine; Psychiatric Status Rating Scales; Quinazolines; Research Design; Sertraline; Treatment Outcome | 2016 |
7 other study(ies) available for quinazolines and buquineran
| Article | Year |
|---|---|
The inotropic effects of UK 14,275, a phosphodiesterase inhibitor, in man.
Topics: Adult; Drug Interactions; Humans; Isoproterenol; Male; Myocardial Contraction; Phosphodiesterase Inhibitors; Piperidines; Propranolol; Quinazolines; Stimulation, Chemical | 1978 |
Cardiovascular effects of a new inotropic drug in dog and normal man.
Topics: Animals; Blood Pressure; Cardiac Output; Dogs; Half-Life; Heart Rate; Hemodynamics; Humans; Male; Myocardial Contraction; Piperidines; Quinazolines | 1976 |
Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Amrinone; Animals; Carbamates; Cardiotonic Agents; Cyclic AMP; Cyclic GMP; Dogs; Kinetics; Milrinone; Myocardium; Peptide Hydrolases; Pyridazines; Pyridones; Quinazolines; Trypsin | 1987 |
Spin-labeled phorbol esters and their interactions with cellular membranes. III. Skin irritant and tumor-promoting activities of spin-labeled phorbol-12,13-diesters and relationships to their particular structures.
Topics: Animals; Female; Indicators and Reagents; Irritants; Mice; Mice, Inbred Strains; Molecular Structure; Quinazolines; Skin; Skin Neoplasms; Spin Labels; Structure-Activity Relationship | 1988 |
Bombesin and phorbol ester stimulate phosphatidylcholine hydrolysis by phospholipase C: evidence for a role of protein kinase C.
Topics: Animals; Bombesin; Carcinogens; Cells, Cultured; Hydrolysis; Kinetics; Mice; Phosphatidylcholines; Phospholipids; Protein Kinase C; Quinazolines; Tetradecanoylphorbol Acetate; Type C Phospholipases | 1987 |
Influence of extracellular ions on cardiotonic effects of BDPU [1-(butyl-3 (1-(6,7 dimethoxyquinazoline 4-yl) piperidine 4-yl) urea)].
Topics: Animals; Calcium Chloride; Dose-Response Relationship, Drug; Drug Synergism; Female; Male; Myocardial Contraction; Phosphodiesterase Inhibitors; Potassium Chloride; Quinazolines; Ranidae; Sodium Chloride; Stimulation, Chemical | 1983 |
A "Sleeping Beauty" With a "Heart-Hand": Kleine-Levin Syndrome Treated With Buproprion and Carbamazepine in a Patient With Holt-Oram Syndrome.
Topics: Abnormalities, Multiple; Adult; Carbamazepine; Electroencephalography; Female; Heart Defects, Congenital; Heart Septal Defects, Atrial; Humans; Kleine-Levin Syndrome; Lower Extremity Deformities, Congenital; Quinazolines; Upper Extremity Deformities, Congenital | 2017 |